Virtu Financial LLC Agenus Inc Transaction History

Virtu Financial LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 26, 2024	BUY	$0.63 - $1.14 $162,185 - $293,478	257,437 New	257,437 $213,000
Q3 2022 Nov 07, 2022	BUY	$1.96 - $3.14 $149,965 - $240,250	76,513 New	76,513 $157,000
Q4 2021 Feb 17, 2022	SELL	$2.92 - $5.74 $60,417 - $118,766	-20,691 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$4.98 - $6.63 $103,041 - $137,181	20,691 New	20,691 $109,000
Q1 2021 May 19, 2021	SELL	$2.69 - $5.25 $147,646 - $288,156	-54,887 Closed	0 $0
Q4 2020 Feb 24, 2021	SELL	$3.17 - $4.49 $4,504 - $6,380	-1,421 Reduced 2.52%	54,887 $175,000
Q3 2020 Dec 11, 2020	BUY	$2.98 - $5.2 $167,797 - $292,801	56,308 New	56,308 $225,000
Q4 2019 Feb 04, 2020	SELL	$2.41 - $4.4 $62,563 - $114,224	-25,960 Closed	0 $0
Q3 2019 Nov 20, 2019	BUY	$2.17 - $3.14 $15,474 - $22,391	7,131 Added 37.87%	25,960 $67,000
Q2 2019 Aug 13, 2019	BUY	$2.53 - $3.04 $47,637 - $57,240	18,829 New	18,829 $56,000
Q1 2019 Apr 12, 2019	SELL	$2.51 - $3.73 $101,702 - $151,135	-40,519 Closed	0 $0
Q4 2018 Jan 16, 2019	SELL	$1.59 - $2.66 $13,871 - $23,205	-8,724 Reduced 17.72%	40,519 $96,000
Q3 2018 Nov 13, 2018	SELL	$1.59 - $2.42 $36,317 - $55,275	-22,841 Reduced 31.69%	49,243 $105,000
Q1 2018 May 14, 2018	BUY	$3.51 - $6.04 $253,014 - $435,387	72,084 New	72,084 $340,000

2.07M

Ticker AGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 283,163,008
Market Cap $4.73B
Description
Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.